AstraZeneca's total assets for Q2 2025 were $112.42B, an increase of 5.81% from the previous quarter. GB:AZN total liabilities were $67.61B for the fiscal quarter, a 3.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.